Automated Microinjection of Recombinant BCL-X into Mouse Zygotes Enhances Embryo Development
Author Information
Author(s): Liu Xinyu, Fernandes Roxanne, Gertsenstein Marina, Perumalsamy Alagammal, Lai Ingrid, Chi Maggie, Moley Kelle H., Greenblatt Ellen, Jurisica Igor, Casper Robert F., Sun Yu, Jurisicova Andrea
Primary Institution: University of Toronto
Hypothesis
Can microinjection of recombinant BCL-XL protein improve embryo development in suboptimal culture conditions?
Conclusion
Microinjection of recombinant BCL-XL protein significantly improves preimplantation embryo development and quality in suboptimal culture conditions.
Supporting Evidence
- Robotic microinjection achieved a low cell lysis rate of 1.1%.
- Blastocyst formation rate was 89±1.3% after microinjection.
- Microinjection of recBCL-XL significantly reduced reactive oxygen species levels.
- Embryos injected with recBCL-XL showed improved mitochondrial distribution.
Takeaway
Scientists created a robot that helps inject a special protein into mouse embryos to help them grow better, especially when the conditions aren't great.
Methodology
The study involved developing a robotic microinjection system to deliver recombinant BCL-XL protein into mouse zygotes and assessing the effects on embryo development.
Limitations
The study primarily focused on mouse embryos, which may not fully translate to human embryos.
Participant Demographics
Mouse zygotes were used in the experiments.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website